Rebecca Jane Cox Brokstad
Position
Professor, Head of the Influenza Centre
Affiliation
- rebecca.cox@uib.no
- Phone number
- +47 45242974
- Visitor address
-
5th Floor Laboratory Building Jonas Leis vei 87
5021 Bergen - Room: Office address: Room 114 Armauer Hansens Hus
- Postal address
-
P.O. Box 7804NO-5020 BergenNorway
Rebecca Jane Cox Brokstad
Position
Professor, Head of the Influenza Centre
Affiliation
Research groups
Short info
Rebecca heads the Influenza Centre with a vision is to reduce the global burden of respiratory illness through being an international leader in control and treatment of pandemic/epidemic viruses. She is a member of the Norwegian Academy of Science and Letters, an advisor to the WHO, EMA and EU.
Research
Rebecca har more than 30 years of experience in influenza research. The key competence of the Influenza Centre is development and clinical evaluation of novel and pandemic vaccines as well as cohort studies of infected patients focusing on immunological responses with long term follow up.
Outreach
Rebecca won the Meltzer prize for excellent scientific dissemination in 2022 in recognition of her work in public dissemination. She frequently contributes to news through interviews and chronicles on television, the radio, in the newspapers, online and magazines about COVID-19, influenza and vaccines including >400 media interviews during the COVID pandemic.
Teaching
Rebecca actively participates in teaching of Virology, Immunology and Vaccinology of undergraduate and postgraduate (masters and Ph.D., medical doctors undergoing specialisation) students in medicine, pharmacy, dentistry and cell biology. She chairs the education committee for the learned society Influenza and other respiratory viruses.
Publications
Academic article
- Nina Urke Ertesvåg; Rebecca Jane Cox; Sarah Larteley Lartey Jalloh et al. (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. (external link)
- Jon Salmanton-García; Fiona A. Stewart; Sarah Heringer et al. (2022). VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment. (external link)
- Pål Voltersvik; Lara Adnan Aqrawi; Susanne Gjeruldsen Dudman et al. (2016). Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study. (external link)
- Claudia Maria Trombetta; Cristina Ulivieri; Rebecca Jane Cox et al. (2018). Impact of erythrocyte species on assays for influenza serology. (external link)
- Rebecca Jane Cox; Abdullah Sami Madhun; Solveig Hauge et al. (2009). A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. (external link)
- Gabriel Kristian Pedersen; Haakon Sjursen; Jane Kristin Nøstbakken et al. (2014). Matrix M™ adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man. (external link)
- Arild Iversen; Bjørn Blomberg; Kjell Haug et al. (2024). Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway. (external link)
- Heidi Syre; Marius Eduardo Brå Obreque; Ingvild Dalen et al. (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. (external link)
- Albin Björk; Gudny Ella Thorlacius; Johannes Mofors et al. (2020). Viral antigens elicit augmented immune responses in primary Sjögren's syndrome. (external link)
- Therese Bredholt Onyango; Fan Zhou; Geir Bredholt et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (external link)
- Joanna Waldock; Edmond J. Remarque; Lingyi Zheng et al. (2023). Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study. (external link)
- Sarah Begue; Gwenn Waerlop; Bruno Salaun et al. (2022). Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4<sup>+</sup> T cell immunity within the FLUCOP consortium. (external link)
- Anne Mette Koch; Roy Miodini Nilsen; Hanne-Merete Eriksen et al. (2015). Mortality related to hospital-associated infections in a tertiary hospital; repeated cross-sectional studies between 2004-2011. (external link)
- Joanna Waldock; Lingyi Zheng; Edmond J. Remarque et al. (2021). Assay harmonization and use of biological standards to improve the reproducibility of the hemagglutination inhibition assay: A FLUCOP collaborative study. (external link)
- Signe Svindland; Gabriel Kristian Pedersen; Rishi Pathirana et al. (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. (external link)
- Jack Alwin Panapasa; Rebecca Jane Cox; Kristin Greve Isdahl Mohn et al. (2015). The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. (external link)
- Linda M. Biesty; Sarah Sheehan; Pauline Meskell et al. (2024). Factors that influence recruitment to COVID-19 vaccine trials: a qualitative evidence synthesis. (external link)
- Signe Svindland; Åsne Jul-Larsen; Rishi Pathirana et al. (2012). The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. (external link)
- Solveig Hauge; Abdullah Sami Madhun; Rebecca Jane Cox et al. (2007). Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies. (external link)
- Aleksandr Ianevski; Eva Zusinaite; Suvi Kuivanen et al. (2018). Novel activities of safe-in-human broad-spectrum antiviral agents. (external link)
- Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (external link)
- Karl Albert Brokstad; Marita Fredriksen; Fan Zhou et al. (2018). T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome. (external link)
- Abdullah Sami Madhun; Per Espen Akselsen; Haakon Sjursen et al. (2010). An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. (external link)
- Joanna Waldock; Carol D. Weiss; Wei Wang et al. (2023). An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study. (external link)
- Sarah Tete; Åsne Jul-Larsen; Sina Rostami et al. (2018). Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. (external link)
- Ewa Alicja Szyszko; Karl Albert Brokstad; Rebecca Jane Cox et al. (2006). Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. (external link)
- Rebecca Jane Cox; E Mykkeltvedt; J Robertson et al. (2002). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (external link)
- Esperanza Diaz Perez; Svenn-Erik Mamelund; Jarle Eid et al. (2021). Learning from the COVID-19 pandemic among migrants: An innovative, system-level, interdisciplinary approach is needed to improve public health. (external link)
- Camilla Tøndel; Synne Jenum; Kristian Tonby et al. (2026). SARS-CoV-2 T-cell vaccine VB10.2210 induces broad T-cell responses in a phase 1/2 open-label clinical trial. (external link)
- Amit Bansal; Ida Sofie Karlsen Sletten; Le, Tung Thanh et al. (2026). Systematic review protocol: evaluation of candidate platforms and vaccines for emerging and re-emerging viral threats | Systematic Reviews. (external link)
- Johanna Eva Bodin; Gro Tunheim; Anja Bråthen Kristoffersen et al. (2025). High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim (2005). Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. (external link)
- Gabriel Pedersen; Diane Major; Sarah Roseby et al. (2011). Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model. (external link)
- Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2016). Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.. (external link)
- Aleksandr Ianevski; Eva Zusinaite; Nastassia Shtaida et al. (2019). Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010-2018. (external link)
- Audun Aase; Halvor Sommerfelt; Lizette Balle Petersen et al. (2016). Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction. (external link)
- Nina Urke Ertesvåg; Julie Xiao; Fan Zhou et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (external link)
- Rebecca Jane Cox; Diane Major; Gabriel Kristian Pedersen et al. (2015). Matrix M H5N1 vaccine induces cross-H5 clade humoral immune responses in a randomized clinical trial and provides protection from highly pathogenic influenza challenge in ferrets. (external link)
- Julie Zimmermann; Signe Tandrup Schmidt; Ramona Trebbien et al. (2022). A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease. (external link)
- Mai Chi Trieu; Amit Bansal; Anders Madsen et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
- Camilla Tvedt Ekanger; Nilima Dinesh Kumar; Rosanne W. Koutstaal et al. (2025). Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies. (external link)
- Hilde Marie Torgauten; Therese Bredholt Onyango; Sonja Ljostveit et al. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. (external link)
- Karl Albert Brokstad; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2002). Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. (external link)
- Christos D. Argyropoulos; Janina Leckler; Jon Salmanton-García et al. (2023). Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit. (external link)
- Joanne Byrne; Lili Gu; Alejandro Garcia-Leon et al. (2024). Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection. (external link)
- Henning Kristian Olberg; Geir Egil Eide; Rebecca Jane Cox et al. (2018). Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. (external link)
- Grace Kenny; Sophie O’Reilly; Neil Wrigley Kelly et al. (2023). Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time. (external link)
- Arnt-Ove Hovden; Karl Albert Brokstad; Diane Major et al. (2009). A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. (external link)
- Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Rishi Pathirana et al. (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. (external link)
- Claudia Maria Trombetta; Daniele Perini; Licia Vitale et al. (2015). Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses. (external link)
- Camilla Tvedt Ekanger; Fan Zhou; Dana Bohan et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (external link)
- Florian Krammer; Jerry P. Weir; Othmar Engelhardt et al. (2019). Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. (external link)
- Åsne Jul-Larsen; Abdullah Sami Madhun; Karl Albert Brokstad et al. (2012). The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants. (external link)
- Pauline Meskell; Linda M Biesty; Maura Dowling et al. (2022). Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis. (external link)
- Synnøve Eidem; Sarah Tete; Åsne Jul-Larsen et al. (2015). Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations. (external link)
- Abdullah Sami Madhun; Lars Reinhardt Haaheim; Jane Kristin Nøstbakken et al. (2011). Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4(+) cells and strong mucosal and systemic antibody responses in mice. (external link)
- Steinar Skrede; Hans Steinsland; Halvor Sommerfelt et al. (2014). Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward. (external link)
- Irina Meln; Victor Cnossen; Nicoletta Corti et al. (2025). Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report. (external link)
- Saranya Sridhar; Karl Albert Brokstad; Rebecca Jane Cox (2015). Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines. (external link)
- Thomas Ebensen; Jennifer Debarry; Gabriel Kristian Pedersen et al. (2017). Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice. (external link)
- Anders Madsen; Ya-Nan Dai; Meagan McMahon et al. (2020). Human antibodies targeting influenza B virus neuraminidase active site are broadly protective. (external link)
- Delphine Héquet; Manuel Pascual; Sarah Larteley Lartey et al. (2016). Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. (external link)
- Lena Hansen; Meagan McMahon; Hannah L. Turner et al. (2023). Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo. (external link)
- Lena Hansen; Karl Albert Brokstad; Amit Bansal et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (external link)
- John Mair-Jenkins; Maria Saavedra-Campos; J. Kenneth Baillie et al. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox Brokstad; Jens-Christian Eriksson et al. (2001). High prevalence of influenza specific antibody secreting cells in nasal mucosa. (external link)
- Johanna Eva Bodin; Adane Mihret; Carol J C Holm-Hansen et al. (2019). Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia. (external link)
- Gemma Pidelaserra Marti; Kristin Greve Isdahl Mohn; Rebecca Jane Cox et al. (2014). The Influence of Tonsillectomy on Total Serum Antibody Levels. (external link)
- Abdullah Sami Madhun; Mona Vibece Nilsen; Lars Reinhardt Haaheim et al. (2009). Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice. (external link)
- Gwenn Waerlop; Geert Leroux-Roels; Anke Pagnon et al. (2023). Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. (external link)
- Rebecca Jane Cox Brokstad; Eva Mykkelstveit; James Robertson et al. (2001). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (external link)
- Jon Salmanton-García; Pauline Wipfler; Paula Valle-Simón et al. (2023). VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. (external link)
- Sarah Larteley Lartey; Rishi Pathirana; Fan Zhou et al. (2015). Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. (external link)
- Tomas Mikal Eagan; Jon Andrew Hardie; Åsne Jul-Larsen et al. (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. (external link)
- Kristian Anton Simonsen; Steinar Hunskaar; Knut-Arne Wensaas et al. (2011). Influenza-like illness in general practice in Norway: clinical course and attitudes towards vaccination and preventive measures during the 2009 pandemic. (external link)
- Florian Krammer; Randy A. Albrecht; Gene S. Tan et al. (2014). Divergent H7 immunogens offer protection from H7N9 virus challenge. (external link)
- Peggy Riese; Stephanie Trittel; Rishi Pathirana et al. (2020). Responsiveness to influenza vaccination correlates with nkg2c-expression on nk cells. (external link)
- Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Shahinul Islam et al. (2020). Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. (external link)
- Anders Madsen; Åsne Jul-Larsen; Mai Chi Trieu et al. (2021). Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response. (external link)
- Bjørn Sætrevik; Rebecca Jane Cox; Dagrun Waag Linchausen et al. (2025). Perceived infection risk, infection exposure, and compliance to infection control measures among the first COVID-19 patients in Norway. (external link)
- Anne Mette Koch; Roy Miodini Nilsen; Anne Dalheim et al. (2015). Need for more targeted measures - Only less severe hospital-associated infections declined after introduction of an infection control program. (external link)
- Diane Major; Jessica A. Chichester; Rishi Pathirana et al. (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. (external link)
- Teddy John Wohlbold; Raffael Nachbagauer; Haoming Xu et al. (2015). Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. (external link)
- Bjørn Blomberg; Kristin Greve-Isdahl Mohn; Karl Albert Brokstad et al. (2021). Long COVID in a prospective cohort of home-isolated patients. (external link)
- Rebecca Jane Cox; Diane Major; Solveig Hauge et al. (2009). A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. (external link)
- Gabriel Pedersen; Alfred Halstensen; Haakon Sjursen et al. (2011). Pandemic Influenza Vaccination Elicits Influenza-Specific CD4(+) Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. (external link)
- Sarah Larteley Lartey Jalloh; Fan Zhou; Karl Albert Brokstad et al. (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. (external link)
- Kristin Greve-Isdahl Mohn; Birger Norderud Lærum; Steinar Skrede et al. (2013). Reduced Hospital Stay in Influenza Patients after Mass Vaccination during the 2009 Influenza Pandemic in Norway. (external link)
- Thor Ueland; Rebecca Jane Cox; Annika Elisabet Michelsen et al. (2025). Markers of T cell activation and exhaustion in plasma are associated with persistent symptoms up to 18 months following mild SARS-CoV-2 infection. (external link)
- Miloje Savic; Jennifer Lynn Dembinski; Ida Laake et al. (2017). Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy. (external link)
- Gabriel Pedersen; Abdullah Sami Madhun; Lucy Breakwell et al. (2012). T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. (external link)
- Gro Tunheim; Ida Laake; Anna Hayman Robertson et al. (2018). Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness. (external link)
- Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (external link)
- Håkon Amdam; Anders Madsen; Fan Zhou et al. (2021). Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). (external link)
- Elisabeth Berg Fjelltveit; Rebecca Jane Cox Brokstad; Jørgen Østensjø et al. (2020). Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. (external link)
- Tor Kristian Andersen; Fan Zhou; Rebecca Jane Cox et al. (2017). A DNA vaccine that targets hemagglutinin to antigen-presenting cells protects mice against H7 influenza. (external link)
- Rebecca Jane Cox Brokstad; Eva Mykkelstveit; Haakon Sjursen et al. (2001). The effect of zanamivir treatment on the early immune response to influenza vaccination. (external link)
- Nina Urke Ertesvåg; Arild Iversen; Bjørn Blomberg et al. (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. (external link)
- Rebecca Jane Cox; Lars Reinhardt Haaheim; Jens Christian Eriksson et al. (2006). The humoral and cellular responses induced locally and systematically after parenteral influenza vaccination in man. (external link)
- Rishi Pathirana; Geir Bredholt; Per Espen Akselsen et al. (2012). A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination. (external link)
- Hongxing Hu; Fan Zhou; Xiaoli Ma et al. (2025). Targeted barcoding of variable antibody domains and individual transcriptomes of the human B-cell repertoire using Link-Seq. (external link)
- Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (external link)
- Shahinul Islam; Kristin Greve Isdahl Mohn; Florain Krammer et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (external link)
- Shahinul Islam; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (external link)
- Raffael Nachbagauer; Teddy John Wohlbold; Ariana Hirsh et al. (2014). Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. (external link)
- Elisabeth Berg Fjelltveit; Bjørn Blomberg; Kanika Kuwelker et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (external link)
- Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2018). Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)
- Catarina Luís; Verónica Romina Di Marzo; Mandeep Kaur et al. (2022). Vaccination rates in Europe are not associated with online media intensity. (external link)
- Sudhir Venkatesan; Rebecca Jane Cox; Jonathan S. Nguyen-Van-tam et al. (2016). Interpandemic (Seasonal) influenza. (external link)
- Jennifer Lynn Dembinski; Adane Mihret; Abebe Yimer Solomon et al. (2017). High prevalence of humoral and cellular immunity to influenza viruses in preschool children living in Addis Ababa, Ethiopia. (external link)
- Kanika Kuwelker; Fan Zhou; Bjørn Blomberg et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (external link)
- Fan Zhou; Juha Vahokoski; Siri Øyen et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (external link)
- Lena Hansen; Fan Zhou; Håkon Amdam et al. (2021). Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Abdullah Sami Madhun et al. (2005). Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. (external link)
- Alex Mann; Nicolas Noulin; Andrew Catchpole et al. (2014). Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge. (external link)
- Sarah Tete; Florain Krammer; Sarah Larteley Lartey Jalloh et al. (2016). Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination. (external link)
- Korbinian Bösl; Aleksandr Ianevski; Thoa T. Than et al. (2019). Common nodes of virus-host interaction revealed through an integrated network analysis. (external link)
- Mai Chi Trieu; Amit Bansal; Marianne Sævik et al. (2025). Effects of repeated influenza vaccination and infection on durable seroprotection in healthcare workers. (external link)
- Fan Zhou; Lena Hansen; Gabriel Kristian Pedersen et al. (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. (external link)
- Trung Tran; Eline Benno Vaage; Adi Mehta et al. (2022). Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. (external link)
- Florian Krammer; Jacqueline M. Katz; Othmar G. Engelhardt et al. (2024). Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic”. (external link)
- Dimitrios Poulimeneas; Markela Koniordou; Dimitra Kousi et al. (2023). The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium. (external link)
- Alessandro Manenti; Sarah Tete; Kristin Greve Isdahl Mohn et al. (2016). Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. (external link)
- Andrew J. Pollard; Robert Sauerwein; Marc Baay et al. (2020). Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report. (external link)
- Bård Reiakvam Kittang; Bjørn Blomberg; Marianne Sævik et al. (2022). SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study. (external link)
- Rebecca Jane Cox Brokstad; Karl Albert Brokstad; Florian Krammer et al. (2020). Seroconversion in household members of COVID-19 outpatients.. (external link)
- Gabriel Pedersen; Alfred Halstensen; Haakon Sjursen et al. (2011). Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenza-specific CD4+Th1-cell responses. (external link)
- Henning Jacobsen; Madhusudan Rajendran; Angela Choi et al. (2017). Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. (external link)
- Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Gro Tunheim et al. (2015). Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. (external link)
- Rebecca Jane Cox; Arnt-Ove Hovden; Karl Albert Brokstad et al. (2006). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
- Federica Sicca; Eleni Sakorafa; Anouk de Jonge et al. (2022). The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority. (external link)
- Anders Madsen; Linda Azimi; Sarah Tete et al. (2019). No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. (external link)
- Marie-Clotilde Bernard; Joanna Waldock; Sylvie Commandeur et al. (2022). Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study. (external link)
- Geir Bredholt; Marianne Sævik; Hanne Søyland et al. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. (external link)
- Elisabeth Berg Fjelltveit; Rebecca Jane Cox; Bård Reiakvam Kittang et al. (2021). Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. (external link)
- Martin Beukema; Shuran Gong; Kasem Al-Jaawni et al. (2023). Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice. (external link)
- Abira Paramsothy; Sarah Larteley Lartey Jalloh; Richard Allan Davies et al. (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. (external link)
- Henning Kristian Olberg; Rebecca Jane Cox; Jane Kristin Nøstbakken et al. (2014). Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. (external link)
- Jennifer Lynn Dembinski; Miloje Savic; Yohan Kim et al. (2016). Epitope specific T-cell responses against influenza A in a healthy population. (external link)
- Florian Krammer; Åsne Jul-Larsen; Irina Margine et al. (2014). An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans. (external link)
- Rebecca Jane Cox; Gabriel Pedersen; Abdullah Sami Madhun et al. (2011). Evaluation of a virosomal H5N1 vaccine formulated with Matrix M (TM) adjuvant in a phase I clinical trial. (external link)
- Kristin Greve-Isdahl Mohn; Geir Bredholt; Fan Zhou et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (external link)
- Kristin Greve Isdahl Mohn; Geir Bredholt; Karl Albert Brokstad et al. (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. (external link)
- Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Fan Zhou et al. (2024). Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine. (external link)
- Monica Trondsen; Lara Adnan Aqrawi; Fan Zhou et al. (2015). Induction of local secretory IgA and multifunctional CD4+ T-helper cells following intranasal immunization with a H5N1 whole inactivated influenza virus vaccine in BALB/c mice. (external link)
- Gabriel Pedersen; Katja Höschler; Sara Marie Øie Solbak et al. (2014). Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. (external link)
- Gabriel Pedersen; Thomas Ebensen; Ingrid Hjetland Gjeraker et al. (2011). Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP. (external link)
- Gwenn Waerlop; Geert Leroux-Roels; Teresa Lambe et al. (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. (external link)
- Kristin Greve Isdahl Mohn; Fan Zhou; Karl Albert Brokstad et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (external link)
- Mai Chi Trieu; Åsne Jul-Larsen; Marianne Sævik et al. (2018). Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: A 5-year follow-up study. (external link)
- Solveig Hauge; Abdullah Sami Madhun; Rebecca Jane Cox et al. (2007). A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice. (external link)
- Amit Bansal; Mai Chi Trieu; Emily M. Eriksson et al. (2025). SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis. (external link)
Media interview
- Rebecca Jane Cox (2018). Man flu. Dette mener ekspertene om «man flu». (external link)
- Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2019). Dette apparatet kan på 15 minutter finne ut om du har influensa. (external link)
- Rebecca Jane Cox (2020). Treng vi å frykte koronaviruse i noreg. (external link)
- Oddgeir Øystese; Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2014). Behandling med Tamiflu reduserte mortaliteten under Pandemien i 2009. (external link)
- Rebecca Jane Cox (2020). 10 kjappe om coronaviruset. (external link)
- Rebecca Jane Cox (2020). Hva skjer om du blir smittet av coronavirus?. (external link)
- Rebecca Jane Cox (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (external link)
- Rebecca Jane Cox (2020). Bør du unngå å ta buss og er koronaviruset farlig for gravide?. (external link)
- Rebecca Jane Cox (2020). Professor om coronaviruset: – Ingen grunn til å bekymre seg for covid-19. (external link)
- Rebecca Jane Cox (2021). Slik kan koronavaksinen beskytte oss mot den neste pandemien. (external link)
- Rebecca Jane Cox (2020). Derfor har ikke sverige strengere krav. (external link)
- Bethen Steenbuch; Gunnveig Grødeland; Rebecca Jane Cox et al. (2023). Venter smittetopp rundt nyttår. Slik kan influensasesongen bli fremover.. (external link)
- Rebecca Jane Cox (2020). influensaeksperten lar seg imponere av bergen. (external link)
- Rebecca Jane Cox (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (external link)
- Rebecca Jane Cox (2020). Hysteri samanlikna med dei gløymde krisene. (external link)
- Klaus Holthe; Gunnveig Grødeland; Rebecca Jane Cox et al. (2022). Ny vaksinestudie: – Svært viktig. (external link)
- Rebecca Jane Cox (2020). 45 i isolasjon på Landås etter skiferie. (external link)
- Rebecca Jane Cox (2020). Oppfyller kriteriene for sykdom x. (external link)
- Rebecca Jane Cox (2020). Hvor farlig er det nye, kinesiske koronaviruset?. (external link)
- Rebecca Jane Cox (2020). Kinesiske forskere har funnet flere risikofaktorer hos dem som døde. (external link)
- Rebecca Jane Cox (2020). Tegnell mener lite influensa forklarer høye koronatall dette svarer norske eksperter.. (external link)
- Rebecca Jane Cox; Camilla Tøndel; Anne Spurkland et al. (2023). Bør alle norske barn vaksineres mot vannkopper?. (external link)
- Bethen Steenbuch; Gunnveig Grødeland; Rebecca Jane Cox et al. (2023). Vaksine mot fugleinfluensa skal testes ut på mennesker i Norge. (external link)
- Bethen Steenbuch; Gunnveig Grødeland; Rebecca Jane Cox (2022). Til høsten kommer trolig en ny virusbølge. Men nå er vi mye bedre forberedt.. (external link)
- Rebecca Jane Cox (2020). 19,5 millioner til koronaforskning ved uib. (external link)
- Rebecca Jane Cox (2020). Virusekspert om Trump-han spilte russisk-rulett. (external link)
- Rebecca Jane Cox (2020). Ni spoersmaal og svar om coronaviruset. (external link)
- Rebecca Jane Cox (2020). Wuhan-viruset sprer seg. Nå tas det drastiske grep over hele verden. (external link)
- Rebecca Jane Cox (2017). Influensasesong. (external link)
- Rebecca Jane Cox (2017). 3000 prøver gav trygge svar om influensavaksinen. (external link)
- Rebecca Jane Cox (2017). Årlege influensavaksinar hindrar ikkje naturleg immunitet. (external link)
- Steinar Westin; Rebecca Jane Cox (2021). Klemmene på innsettelsen av Joe Biden skaper reaksjoner: Disse smittegrepene redder dem.. (external link)
- Gunnveig Grødeland; Rebecca Jane Cox; Bethen Steenbuch et al. (2023). Nå er vinterens smittebølge her: 77.000 sårbare barn er ikke vaksinert. (external link)
- Rebecca Jane Cox (2020). Norsk koronastudie avslører langt høyere smitterisiko i familier enn tidligere påvist. (external link)
- Rebecca Jane Cox (2020). Coronaviruset: Familien til Chen er isolert i Kina. (external link)
- Rebecca Jane Cox (2017). 3000 prøver gav trygge svar om influensavaksinen. (external link)
Lecture
- Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2015). Ytringsfrihet. (external link)
- Rebecca Jane Cox (2021). COVID-19 studie på Vestlandet. (external link)
- Rebecca Jane Cox (2022). Influenza. (external link)
- Rebecca Jane Cox (2022). Post Corona: Samfunn og Helse - Hva er effektene og ettervirkningene?. (external link)
- Rebecca Jane Cox (2020). Sanntidsforskning: Når egen forskning blir livsviktig og dagsaktuell/vitenskapsrådgivning. (external link)
- Rebecca Jane Cox (2021). Overview of novel platforms in influenza vaccine and integrating lessons from COVID-19. (external link)
- Rebecca Jane Cox (2022). Post-covid: Balancing concerns for public health and individual autonomy over own health. The specialist/immunology perspective. (external link)
- Rebecca Jane Cox (2021). Covid-19 infection and vaccination in Western Norway. (external link)
- Rebecca Jane Cox Brokstad (2024). Strategi for Influensavaksinasjon. (external link)
- Rebecca Jane Cox (2017). Hvorfor trenger vi fortsatt vaksiner?. (external link)
- Rebecca Jane Cox (2018). Vaksinering av helsepersonell hva vet vi?. (external link)
- Rebecca Jane Cox (2021). Vaksinasjon og COVID-19 vaksiner. (external link)
- Rebecca Jane Cox Brokstad (2024). Long Covid plager hos barn etter deltainfeksjon og omicron-reinfeksjon. (external link)
- Rebecca Jane Cox (2023). Human Challenge Models panel discussion. (external link)
- Rebecca Jane Cox (2023). Correlates of Protection. (external link)
- Rebecca Jane Cox (2019). Hva er god helse? Når skolemedisin møter vaksinemotstand. (external link)
- Rebecca Jane Cox (2022). Influensavaksiner og covid vaksiner. (external link)
- Rebecca Jane Cox (2020). Immunitet til COVID-19 i Bergen. (external link)
Letter to the editor
- Kristin Greve-Isdahl Mohn; Geir Bredholt; Therese Bredholt Onyango et al. (2023). SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity. (external link)
- Geir Bredholt; Gabriel Pedersen; Rishi Pathirana et al. (2013). A(H1N1)pdm09 Vaccination of Healthcare Workers: Improved Immune Responses in Low Responders Following Revaccination Reply. (external link)
- Solveig Hauge; Abdullah Sami Madhun; Karl Albert Brokstad et al. (2009). The Immunogenicity of a Cell-derived H7N1 Split Influenza Virion Vaccine in Mice. (external link)
- John Wood; Geoffery Schild; Rebecca Jane Cox (2011). Lars R. Haaheim PhD (1945-2011) Obituary. (external link)
Conference poster
- Karl Albert Brokstad; Åke Davidsson; Jens-Christian Eriksson et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (external link)
- Camilla Tvedt Ekanger; Fan Zhou; Karl Albert Brokstad et al. (2024). Comparison of Air-Liquid Interface and Organoid Airway Models for Human Respiratory Virus Infection Studies. (external link)
- Fan Zhou; Juha Vahokoski; Nina Langeland et al. (2022). Kinetics of seasonal and pandemic human coronavirus reactive antibodies after repeated vaccinations in adults and the elderly. (external link)
- Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2015). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (external link)
- Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (external link)
- Amit Bansal; Tung Thanh Le; Stig Tollefsen et al. (2025). Systematic Review Protocol: Establishment and Analysis of Landscapes for Candidate Platforms and Vaccines Against Current and Emerging Viral Threats. (external link)
- Lukas Anders Kryger Hoen; Camilla Tvedt Ekanger; Fan Zhou et al. (2024). Influenza A Variants Formed During Lung Organoid Infection In The Presence of Humoral Immunity. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox Brokstad; Jens-Christian Eriksson et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (external link)
- Lena Hansen; Fan Zhou; Håkon Amdam et al. (2019). Neuraminidase antibody responses after pandemic and seasonal influenza vaccinations: a five-year study. (external link)
- Ingeborg Yddal; Sarah Lartey; Amit Bansal et al. (2023). Immunogenicity after influenza-vaccine in young children and pregnant women in rural Bangladesh. (external link)
- Rebecca Jane Cox; Arnt-Ove Hovden; Abdullah Sami Madhun et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
- Ingeborg Yddal; Sarah Larteley Lartey; Amit Bansal et al. (2023). Influenza-specific antibody responses after Influenza vaccination in young children and pregnant women in rural Bangladesh. (external link)
- Nina Ertesvåg; Mai Chi Trieu; Rebecca Jane Cox (2019). Seasonal influenza vaccination induces broad antibody responses against antigenically distinct A/H3N2 viruses. (external link)
- Lill Trogstad; Siri Mjaaland; Tor Molden et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
- Fan Zhou; Lena Hansen; Tor Kristian Andersen et al. (2019). Adjuvanted H5N1 vaccine elicits rapid and multifaceted humoral immune responses in human. (external link)
- Ingeborg Yddal; Khalequz Zaman; Warda Haque et al. (2023). Respiratory Virus Surveillance in Rural Bangladesh During an Influenza Vaccine Effectiveness Trial of Young Children and Pregnant Women. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox Brokstad; Inger Marie Haaland et al. (2004). The humoral immune response in mice after vaccination and subsequent challenge with live influenza virus. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Abdullah Sami Madhun et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
- Abdullah Sami Madhun; E Szyszko; Rebecca Jane Cox et al. (2005). The cytokine and the antibody responses after vaccination with influenza split or whole virus vaccines in mice. (external link)
- Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2024). Phenotypic and functional changes of human follicular T helper cells over decades of life. (external link)
- Ingeborg Yddal; Sarah Lartey; Warda Haque et al. (2024). Immunogenicity after influenza vaccination in young children <5 years old in rural Bangladesh. (external link)
- Miloje Savic; Jennifer Lynn Dembinski; Ida Laake et al. (2016). The Norwegian Influenza cohort (NorFlu): immune responses in pregnant women during the 2009 H1N1 influenza A pandemic. (external link)
- Bjørn Sætrevik; Rebecca Jane Cox Brokstad; Dagrun Waag Linchausen et al. (2024). Those getting tested for COVID-19 had seen the risk as low, been more exposed and taken fewer precautions. (external link)
- Lena Hansen; Fan Zhou; Rebecca Jane Cox (2019). Neuraminidase Antibody Responses After Pandemic And Seasonal Vaccination: A Five-Year Study. (external link)
- Nina Ertesvåg; Mai Chi Trieu; Rebecca Jane Cox (2019). Seasonal Influenza Vaccination Induces Cross-Reactive Antibodies Against A/H3N2 Viruses. (external link)
- Rebecca Jane Cox Brokstad; Arnt Ove Hovden; Karoline Bragstad et al. (2003). Comparison of the humoral immune response to split and whole virus vaccines in mice. (external link)
- Fan Zhou; Steffen Aleksander Slettevoll; Sarah Larteley Lartey Jalloh et al. (2017). Live attenuated in+luenza vaccine elicits superior follicular T help cell and local antibody responses in children. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Karl Albert Brokstad et al. (2007). Immunisation of mice with whole inactivated avian influenza H7N1 virus vaccine. (external link)
- Ingeborg Yddal; Sarah Larteley Lartey; Warda Haque et al. (2025). Vaccine Response after Quadrivalent Influenza Vaccination in Children <5 Years of Age in Rural Bangladesh. (external link)
- Siri Mjaaland; Siri Eldevik Håberg; Jennifer Lynn Dembinski et al. (2013). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
- Miloje Savic; Jennifer Lynn Dembinski; Ida Laake et al. (2016). Cellular correlates of protection against A(H1N1)pdm09 pandemic influenza during pregnancy. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
- Fan Zhou; Lena Hansen; Gabriel Pedersen et al. (2022). Matrix M adjuvanted H5N1 vaccine elicits broadly neutralizing antibodies and neuraminidase inhibiting antibodies in humans that correlate with in vivo protection. (external link)
- Ingeborg Yddal; Sarah Larteley Lartey Jalloh; Warda Haque et al. (2025). Influenza Vaccine Responses in Young Children in Bangladesh. (external link)
- Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Kristin Greve-Isdahl Mohn et al. (2023). A Comparison of Humoral Responses Induced Following Live Attenuated Influenza Vaccination in Children and Adults. (external link)
- Jens-Christian Eriksson; Karl Albert Brokstad; Rebecca Jane Cox Brokstad et al. (2002). Influenzaspecific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (external link)
- Karl Albert Brokstad; Jens-Christian Haug Eriksson; Rebecca Jane Cox et al. (2005). Cytokine profile and lymphocyte pattern influenced by parenteral influenza vaccination. (external link)
- Amalie Borlaug; Anders Madsen; Sarah Larteley Lartey et al. (2025). Measuring influenza vaccine immunogenicity in young children and pregnant women in Bangladesh. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
- Arnt Ove Hovden; Rebecca Jane Cox Brokstad; Lars Reinhardt Haaheim (2003). The immune response to H7N1 whole virus vaccine in mice. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). Local and systemic immune response to inactivated influenza vaccine. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
- Abdullah El-Madhun; Rebecca Jane Cox Brokstad; Lars Reinhardt Haaheim et al. (2003). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (external link)
- Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Age related decline of T follicular helper cells in children and adults. (external link)
Academic literature review
- Anders Madsen; Rebecca Jane Cox Brokstad (2020). Prospects and challenges in the development of universal influenza vaccines. (external link)
- Kristin Greve Isdahl Mohn; Ingrid Smith; Haakon Sjursen et al. (2017). Immune responses after live attenuated influenza vaccination. (external link)
- Kristine A. Moore; Julia T. Ostrowsky; Alison M. Kraigsley et al. (2021). A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. (external link)
- Steffen Aleksander Slettevoll; Abira Paramsothy; Rebecca Jane Cox (2018). Influensa-alltid relevant. (external link)
- Rebecca Jane Cox; Rishi Delan Pathirana (2024). Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge. (external link)
- Florian Krammer; Rebecca Jane Cox (2013). The emergence of H7N9 viruses: A chance to redefine correlates of protection for influenza virus vaccines. (external link)
- Pauline Meskell; Linda M Biesty; Maura Dowling et al. (2023). Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis. (external link)
- Joanna Waldock; Rebecca Jane Cox; Christopher Chiu et al. (2024). Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK. (external link)
- Fan Zhou; Mai Chi Trieu; Richard Allan Davies et al. (2018). Improving influenza vaccines: challenges to effective implementation. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim (2007). Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. (external link)
- Lars Reinhardt Haaheim; Abdullah Sami Madhun; Rebecca Jane Cox (2009). Pandemic influenza vaccines - the challenges. (external link)
- Rebecca Jane Cox; Karl Brokstad; Pearay Ogra (2004). Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. (external link)
- Jennifer L. McKimm-Breschkin; Alan J. Hay; Bin Cao et al. (2022). COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference. (external link)
- Joanna Waldock; Rebecca Jane Cox; Othmar G. Engelhardt et al. (2024). Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK. (external link)
Doctoral thesis (PhD)
- Shahinul Islam; Rebecca Jane Cox (2019). Live Attenuated Influenza Vaccine (LAIV) Immunization in Children and Adults: Lesson for Development of Universal Influenza Vaccine. (external link)
- Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2016). Immune response to influenza after vaccination and infection. (external link)
- Mai Chi Trieu; Rebecca Jane Cox (2018). Long-term immune response after pandemic and seasonal influenza vaccination in healthcare workers. (external link)
Conference lecture
- Rebecca Jane Cox (2018). Hvorfor trenger vi fremdeles vaksiner? og Influensa en evig kamp.. (external link)
- Rebecca Jane Cox (2022). Covid-19 vaccine evaluation. (external link)
- Rebecca Jane Cox (2022). SARS CoV-2 vaccines, what have we learnt and what is the future. (external link)
- Lill Trogstad; Siri Mjaaland; Tor Molden et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
- Rebecca Jane Cox (2020). COVID-19 in the community and health care system in Bergen. (external link)
- Karl Brokstad; Åke Davidsson; Jens-Christian Eriksson et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (external link)
- Karl Brokstad; Rebecca Jane Cox Brokstad; Jens-Christian Eriksson et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (external link)
- Rebecca Jane Cox (2020). Influensa. (external link)
- Lars Reinhardt Haaheim; Margrethe W. Ibsen; Monica Skogstrand et al. (2001). Antibodies from lymphocytes used as diagnostic markers: A novel approach. (external link)
- Rebecca Jane Cox (2023). Indo-European Consortium for Next Generation Influenza Vaccine Innovation. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Antibody responses to SARS-CoV-2 virus in Norwegian health-care workers: an observational prospective cohort study. (external link)
- Jens-Christian Eriksson; Karl Brokstad; Rebecca Jane Cox Brokstad et al. (2002). Influenza specific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (external link)
- Lars Reinhardt Haaheim; Rebecca Jane Cox; Karl Albert Brokstad et al. (2004). The antibody response to parenteral influenza vaccination � A review of specificity, magnitude, rapidity and shortcomings. (external link)
- Miloje Savic; Ida Laake; Jennifer Lynn Dembinski et al. (2014). The Norwegian Influenza cohort study (NorFlu): immune responses in H1N1 pdm exposed versus non-exposed pregnant women. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox et al. (2001). The level of influenzaspecific antibodysecreting cells in nasal mucosa, prior to an after vaccination. (external link)
- Rebecca Jane Cox (2023). Post COVID-19 condition in children and adolescents after delta infection and omicron reinfection. (external link)
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Low infection and seroconversion rates in frontline healthcare workers during the peak of the Coronavirus disease 2019 pandemic in Bergen, Norway. (external link)
- Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). SARS-COV-2-Specific neutralising antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
- Karl Albert Brokstad; Åke Davidsson; Jens-Christian Eriksson et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (external link)
- Karl Brokstad; Åke Davidsson; Jens-Christian Eriksson et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (external link)
- Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Fan Zhou et al. (2015). Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.. (external link)
- Rebecca Jane Cox (2020). COVID-19 in the community and health care system in Bergen, Norway. (external link)
- Rebecca Jane Cox; Jens-Christian Haug Eriksson; Abdullah Sami Madhun et al. (2005). The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man. (external link)
- Åke Davidsson; Karl Albert Brokstad; Rebecca Jane Cox Brokstad et al. (2001). Influensaantigenspecifika, antikroppsproducerande lymfocyter i human nasal slemhinne. (external link)
- Rebecca Jane Cox Brokstad; Eva Mykkelstveit; Lars Reinhardt Haaheim (2001). DNA vaccination with HA or NP encoding plasmids results in rapid viral clearance after viral challenge. (external link)
- Rebecca Jane Cox (2021). Influenza and SARS-CoV-2 vaccines and the young immune system: should we vaccinate children. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2001). Influenza specific antibody secreting cells (I-ASC)in human nasal mucosa. Relation to tonsil, blood and parenteral vaccination. (external link)
- Rebecca Jane Cox (2020). Case study: Influenza; impact of pre-existing immunity on study end points. (external link)
- Miloje Savic; Ida Laake; Jennifer Lynn Dembinski et al. (2014). The Norwegian Influenza cohort (NorFlu): immune responses in pdmH1N1 exposed versus non-exposed pregnant women. (external link)
- Rebecca Jane Cox (2023). Local Immunity After Influenza Vaccination. (external link)
- Åke Davidsson; Jens-Christian Eriksson; Rebecca Jane Cox Brokstad et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
- Ingeborg Yddal; Sarah Larteley Lartey Jalloh; Anders Madsen et al. (2025). Longevity and functionality of influenza vaccine responses in young children and pregnant women in rural Bangladesh. (external link)
- Amit Bansal; Sam W.Z. Olechnowicz; Nicholas Kiernan-Walker et al. (2025). Plasma proteomic signatures in long COVID: Potential targets for next-generation vaccines. (external link)
- Rebecca Jane Cox (2018). Should we annually vaccinate health care workers against influenza?. (external link)
- Rebecca Jane Cox (2021). Pre-existing immunity and correlates of protection for Influenza. (external link)
- Rebecca Jane Cox (2021). Covid-19 i Bergen. (external link)
- Rebecca Jane Cox (2019). Immune responses to influenza A/H1N1pdm09 virus after adjuvanted pandemic and seasonal influenza vaccination in healthcare workers. (external link)
- Rebecca Jane Cox (2018). Should we vaccinate health care workers against influenza annually?. (external link)
- Rebecca Jane Cox Brokstad; Eva Mykkelstveit; Haakon Sjursen et al. (2001). The effect of relenza treatment on the early immune response induced after influenza vaccination. (external link)
- Rebecca Jane Cox (2018). Subject selection and screening for susceptibility to challenge. (external link)
- Rebecca Jane Cox (2018). Using human influenza vaccine studies to define next generation vaccines. (external link)
- Fan Zhou; Juha Vahokoski; Florian Krammer et al. (2023). Age related differences in kinetics and magnitude of SARS-CoV-2 and endemic human coronavirus reactive antibody responses after vaccination and infection. (external link)
- Korbinian Bösl; Aleksandr Ianevski; Thoa T. Than et al. (2019). Critical Nodes of Viral Modulation Revealed Through an Integrated Network Analysis of Host-Virus Interaction Landscape. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox; Jens-Christian Eriksson et al. (2001). The basal level of influenza specific antibody secreting cells in healthy subjects. (external link)
Editorial/Leader article
- Gabriel Pedersen; Rebecca Jane Cox (2012). The mucosal vaccine quandary Intranasal vs. sublingual immunization against influenza. (external link)
- Rebecca Jane Cox; Karl Albert Brokstad; Lars Reinhardt Haaheim (2006). Pandernic influenza vaccine development: time is of the essence. (external link)
- Rebecca Jane Cox; Karl Albert Brokstad; Lars Reinhardt Haaheim (2006). Pandemic influenza vaccine development: time is of the essence. (external link)
- Rebecca Jane Cox (2013). Correlates of protection to influenza virus, where do we go from here?. (external link)
- Michael Schotsaert; Rebecca Jane Cox; Corey P. Mallett (2022). Editorial: Pandemic influenza vaccine approaches: Current status and future directions. (external link)
Media feature article
- Rebecca Jane Cox Brokstad; Karl Albert Brokstad (2020). Not just antibodies: B cells and T cells mediate immunity to COVID-19.. (external link)
- Sven Even F. Borgos; Rebecca Jane Cox Brokstad; Gunnveig Grødeland et al. (2025). Norge bør utvikle og produsere vaksiner. USA er bare én av grunnene til det. (external link)
- Nina Ertesvåg; Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2018). Få en influensafri jul!. (external link)
- Rebecca Jane Cox Brokstad; Karl Albert Brokstad (2020). CoVid-19; Derfor vil ikke dødeligheten være stor hvis viruset spres i Norge Norsk helsevesen er godt forberedt på at Wuhan-viruset kan spre seg til landet og beredskapen er på plass.. (external link)
- Gunnveig Grødeland; Rebecca Jane Cox; Kristin Greve-Isdahl Mohn et al. (2024). Hvor bekymret skal vi være for fugleinfluensa? Ganske.. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox Brokstad (2020). Det er ikke bare antistoffer som beskytter mot covid-19.. (external link)
- Sven Even F. Borgos; Hanne Haslene-Hox; Gunnveig Grødeland et al. (2025). Norge bør utvikle og produsere vaksiner. USA er bare én av grunnene til det. (external link)
- Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2017). Gravide – se opp for fake news!. (external link)
- Sven Even F. Borgos; Hanne Haslene-Hox; Gunnveig Grødeland et al. (2025). Norge bør utvikle og produsere vaksiner. USA er bare én av grunnene til det. (external link)
- Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2017). Nok tro og folelser na. (external link)
- Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2015). Sølje Bergman er farligere for barn enn vaksiner. (external link)
Journal corrigendum
- Mai Chi Trieu; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2018). Publisher Correction: Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)
- Trung Tran; Eline Benno Vaage; Adi Mehta et al. (2023). Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants (npj Vaccines, (2022), 7, 1, (174), 10.1038/s41541-022-00586-7). (external link)
Study protocol
- Bjørn Blomberg; Nikolai Norevik Myklebust; Oddvar Oppegaard et al. (2025). Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial | Trials | Full Text. (external link)
- Amit Bansal; Ida Sofie Karlsen Sletten; Tung Thanh Le et al. (2025). Systematic Review Protocol: Establishment and Analysis of Landscapes for Candidate Platforms and Vaccines Against Current and Emerging Viral Threats. (external link)
Academic book chapter
- Karl Albert Brokstad; Rebecca Jane Cox Brokstad; Lars Reinhardt Haaheim (2003). Detection of antibodies to influenza virus in human mucosal tissues and fluids. (external link)
- Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim (2004). The immune response to H7N1 whole virus vaccine in mice. (external link)
- Abdullah Sami Madhun; Rebecca Jane Cox; Lars Reinhardt Haaheim et al. (2004). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (external link)
- Rebecca Jane Cox; Arnt-Ove Hovden; Karoline Bragstad et al. (2004). Comparison of the humoral immune response to split and whole virus vaccines in mice. (external link)
Radio or TV participation
Professional article
- Haakon Sjursen; Kristine Livsdatter Aukland Talhaug; Kristin Greve Isdahl Mohn et al. (2018). Immunrespons etter levende svekket influensavksine. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox Brokstad (2021). SARS-CoV-2; Mutasjoner og Varianter.. (external link)
- Karl Albert Brokstad; Rebecca Jane Cox (2021). SARS-CoV-2; livssyklus, mutasjoner, immunreaksjoner og vaksiner. (external link)
Popular science article
Conference abstract
- Gabriel Pedersen; Rebecca Jane Cox (2011). Influenza Specific T-Cell Responses Predict Later Neutralizing Antibody Titres in a Phase 1 Clinical Trial of a Virosomal H5N1 Vaccine Adjuvanted with Matrix-M. (external link)
- Ingrid Hjetland Gjeraker; Gabriel Pedersen; Signe Svindland et al. (2011). Comparison of Different Routes of Administration for Influenza Vaccines in a Murine Model. (external link)
Projects
2023-26 KlinBeForsk Interventions against Long-COVID in Norway (PanoramicNorway). 6 partners. Partner. Budget: 20 million NOK
2021-26 EU IMI2 Innovations to accelerate vaccine development vaccine development and manufacture (Inno4Vac). 41 partners. WP leader Budget: €18.6 million.
2021-25 EU H2020. European Corona Vaccine Trial Accelerator Platform. (Vaccelerate). 31 partners. National coordinator and WP leader Budget: €12 million.
2020-25 EU H2020 Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE). 19 partners. Partner PI children’s clinical trial. Budget: €6 million
2019-25 Research Council of Norway (RCN) An effectiveness trial (phase IV) to evaluate protection of children and pregnant women by influenza vaccine in rural Bangladesh. 3 Partners. Coordinator - RJ. Cox. Budget: 16.9 million NOK